Drug name - Trilipix

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7259186 ABBVIE Salts of fenofibric acid and pharmaceutical formulations thereof
Jan, 2025

(2 years from now)

CN101480384A ABBVIE Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof
Apr, 2012

(10 years ago)

CN100473378C ABBVIE Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Preparation
Dec, 2023

(1 year, 2 months from now)

CN1726024A ABBVIE Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Preparation
Dec, 2023

(1 year, 2 months from now)

EP1572190B1 ABBVIE Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof
Dec, 2023

(1 year, 2 months from now)

EP1572190A1 ABBVIE Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof
Dec, 2023

(1 year, 2 months from now)

Drugs and Companies using CHOLINE FENOFIBRATE ingredient

Treatment: NA

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG FENOFIBRIC ACID CAPSULE, DELAYED RELEASE;ORAL Prescription
EQ 135MG FENOFIBRIC ACID CAPSULE, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.